Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05635396

Seizures Detection in Real Life Setting

Conditions: Epilepsy; Seizure, Focal Epilepsy

Sex: All
Ages: 7 Years – N/A
Phase: NA
Enrollment: 12
Sponsor: Reliev Technologies

Summary

Epilepsy is a disabling neurological disease that affects tens of millions of people worldwide. Despite therapeutic advances, about a third of these patients suffer from treatment-resistant forms of epilepsy and still experience regular seizures.All seizures can last and lead to status epilepticus, which is a major neurological emergency. Epilepsy can also be accompanied with cognitive or psychiatric comorbidities.Reliable seizures count is an essential indicator for estimating the care quality and for optimizing treatment. Several studies have highlighted the difficulty for patients to keep a reliable seizure diary due for example to memory loss or perception alterations during crisis. Whatever the reasons, it has been observed that at least 50% of seizures are on average missed by patients.Seizure detection has been widely developed in recent decades and are generally based on physiological signs monitoring associated with biomarkers search and coupled with detection algorithms. Multimodal approaches, i.e. combining several sensors at the same time, are considered the most promising.Mobile or wearable non invasive devices, allowing an objective seizures documentation in daily life activities, appear to be of major interest for patients and care givers, in detecting and anticipating seizures occurence.This single-arm exploratory, multicenter study aims at assessing whether the use of such a non-invasive, wearable device can be useful in a real life setting in detecting seizures occurence through multimodal analysis of various parameters (heart rate, respiratory and accelerometry).

Eligibility Criteria

Inclusion Criteria:Patients aged 7 years old or morePatients with drug-resistant focal epilepsyPatients with high frequency seizures according to investigator's judgementPatients that can be followed 4 weeks after inclusionInformed consent form signed.Exclusion Criteria:Generalised tonic-clonic seizuresFrequent psychogenic non-epileptic seizuresPregnant or breastfeeding patientsPatients displaying sensor contraindications

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05635396). StuddyBuddy aggregates publicly available trial information.